Jim Simons Exicure, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Exicure, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 14,900 shares of XCUR stock, worth $38,442. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,900
Previous 65,600
77.29%
Holding current value
$38,442
Previous $39,000
89.74%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XCUR
# of Institutions
16Shares Held
766KCall Options Held
0Put Options Held
0-
Abingworth LLP London, X0282KShares$726,6200.11% of portfolio
-
Carlyle Group Inc. Washington, DC282KShares$726,6200.01% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$145,8190.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA46KShares$118,6850.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.1KShares$103,4390.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $12.8M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...